Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
NCT02090127
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Mullerian Mixed Tumor of Ovary
Interventions
DRUG:
ficlatuzumab
Sponsor
AVEO Pharmaceuticals, Inc.